Gold Nanoparticles: Construction for Drug Delivery and Application in Cancer Immunotherapy

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2023 Jul 29

PMID 37514054

Authors

Huiqun Huang

Ronghui Liu

Jie Yang

Jing Dai

Shuhao Fan

Jiang Pi

Yubo Wei

Xinrong Guo

Affiliations

Soon will be listed here.

Abstract

Cancer immunotherapy is an innovative treatment strategy to enhance the ability of the immune system to recognize and eliminate cancer cells. However, dose limitations, low response rates, and adverse immune events pose significant challenges. To address these limitations, gold nanoparticles (AuNPs) have been explored as immunotherapeutic drug carriers owing to their stability, surface versatility, and excellent optical properties. This review provides an overview of the advanced synthesis routes for AuNPs and their utilization as drug carriers to improve precision therapies. The review also emphasises various aspects of AuNP-based immunotherapy, including drug loading, targeting strategies, and drug release mechanisms. The application of AuNPs combined with cancer immunotherapy and their therapeutic efficacy are briefly discussed. Overall, we aimed to provide a recent understanding of the advances, challenges, and prospects of AuNPs for anticancer applications.

Citing Articles

An Evaluation of the Potential Radiosensitization Effect of Spherical Gold Nanoparticles to Induce Cellular Damage Using Different Radiation Qualities.

Engelbrecht-Roberts M, Miles X, Vandevoorde C, de Kock M Molecules. 2025; 30(5).

PMID: 40076263 PMC: 11902069. DOI: 10.3390/molecules30051038.

Integrating computational insights in gold nanoparticle-mediated drug delivery: enhancing efficacy and precision.

Alalmaie A, Alshahrani H, Alqahtani M, Alshahrani Z, Alahmari S, Asiri A Front Med Technol. 2025; 7:1528826.

PMID: 40066057 PMC: 11892449. DOI: 10.3389/fmedt.2025.1528826.

Efficacy of alginate-coated gold nanoparticles against antibiotics-resistant and pathogens of acne origins.

Abbas H, Taha A, Sulaiman G, Al Ali A, Al Shmrany H, Stamatis H Open Life Sci. 2025; 20(1):20221045.

PMID: 40026363 PMC: 11868717. DOI: 10.1515/biol-2022-1045.

Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities.

Rahman M, Jalouli M, Yadab M, Al-Zharani M Cancers (Basel). 2025; 17(4).

PMID: 40002294 PMC: 11852615. DOI: 10.3390/cancers17040701.

Bottom-Up Metasurfaces for Biotechnological Applications.

Petronella F, Zaccagnini F, Sforza M, De Mei V, De Sio L Adv Sci (Weinh). 2025; 12(9):e2413679.

PMID: 39921422 PMC: 11884530. DOI: 10.1002/advs.202413679.

References

Sharma P, Hu-Lieskovan S, Wargo J, Ribas A . Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017; 168(4):707-723. PMC: 5391692. DOI: 10.1016/j.cell.2017.01.017. View

Tang W, Han L, Lu X, Wang Z, Liu F, Li Y . A Nucleic Acid/Gold Nanorod-Based Nanoplatform for Targeted Gene Editing and Combined Tumor Therapy. ACS Appl Mater Interfaces. 2021; 13(18):20974-20981. DOI: 10.1021/acsami.1c02122. View

Hu X, Zhang Y, Ding T, Liu J, Zhao H . Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical Applications and Biological Activities. Front Bioeng Biotechnol. 2020; 8:990. PMC: 7438450. DOI: 10.3389/fbioe.2020.00990. View

Mohammapdour R, Ghandehari H . Mechanisms of immune response to inorganic nanoparticles and their degradation products. Adv Drug Deliv Rev. 2021; 180:114022. PMC: 8898339. DOI: 10.1016/j.addr.2021.114022. View

Rivera Vargas T, Apetoh L . Danger signals: Chemotherapy enhancers?. Immunol Rev. 2017; 280(1):175-193. DOI: 10.1111/imr.12581. View

Xie J, Gong L, Zhu S, Yong Y, Gu Z, Zhao Y . Emerging Strategies of Nanomaterial-Mediated Tumor Radiosensitization. Adv Mater. 2018; 31(3):e1802244. DOI: 10.1002/adma.201802244. View

Luo L, Yang J, Zhu C, Jiang M, Guo X, Li W . Sustained release of anti-PD-1 peptide for perdurable immunotherapy together with photothermal ablation against primary and distant tumors. J Control Release. 2018; 278:87-99. DOI: 10.1016/j.jconrel.2018.04.002. View

Won J, Wi T, Lee C, Lee J, Kang T, Lee J . NIR irradiation-controlled drug release utilizing injectable hydrogels containing gold-labeled liposomes for the treatment of melanoma cancer. Acta Biomater. 2021; 136:508-518. DOI: 10.1016/j.actbio.2021.09.062. View

Jakhmola A, Vecchione R, Onesto V, Gentile F, Profeta M, Battista E . A theoretical and experimental study on l-tyrosine and citrate mediated sustainable production of near infrared absorbing twisted gold nanorods. Mater Sci Eng C Mater Biol Appl. 2020; 118:111515. DOI: 10.1016/j.msec.2020.111515. View

10.

Cui T, Liang J, Chen H, Geng D, Jiao L, Yang J . Performance of Doxorubicin-Conjugated Gold Nanoparticles: Regulation of Drug Location. ACS Appl Mater Interfaces. 2017; 9(10):8569-8580. DOI: 10.1021/acsami.6b16669. View

11.

Cao Y, Ding S, Zeng L, Miao J, Wang K, Chen G . Reeducating Tumor-Associated Macrophages Using CpG@Au Nanocomposites to Modulate Immunosuppressive Microenvironment for Improved Radio-Immunotherapy. ACS Appl Mater Interfaces. 2021; 13(45):53504-53518. DOI: 10.1021/acsami.1c07626. View

12.

Topalian S, Drake C, Pardoll D . Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015; 27(4):450-61. PMC: 4400238. DOI: 10.1016/j.ccell.2015.03.001. View

13.

Silva V, Silva R, Colli L, de Carvalho M, Rodrigues S . Gold nanoparticles carrying or not anti-VEGF antibody do not change glioblastoma multiforme tumor progression in mice. Heliyon. 2020; 6(11):e05591. PMC: 7701192. DOI: 10.1016/j.heliyon.2020.e05591. View

14.

Granja A, Pinheiro M, Sousa C, Reis S . Gold nanostructures as mediators of hyperthermia therapies in breast cancer. Biochem Pharmacol. 2021; 190:114639. DOI: 10.1016/j.bcp.2021.114639. View

15.

You Y, Xu Z, Chen Y . Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer. Drug Deliv. 2018; 25(1):448-460. PMC: 6058718. DOI: 10.1080/10717544.2018.1435746. View

16.

Foroozandeh P, Abdul Aziz A . Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles. Nanoscale Res Lett. 2018; 13(1):339. PMC: 6202307. DOI: 10.1186/s11671-018-2728-6. View

17.

Chen H, Fan Y, Hao X, Yang C, Peng Y, Guo R . Adoptive cellular immunotherapy of tumors via effective CpG delivery to dendritic cells using dendrimer-entrapped gold nanoparticles as a gene vector. J Mater Chem B. 2020; 8(23):5052-5063. DOI: 10.1039/d0tb00678e. View

18.

Chen M, Liu T, Chen Y, Chen M . Combining Augmented Radiotherapy and Immunotherapy through a Nano-Gold and Bacterial Outer-Membrane Vesicle Complex for the Treatment of Glioblastoma. Nanomaterials (Basel). 2021; 11(7). PMC: 8306693. DOI: 10.3390/nano11071661. View

19.

Ma K, Cheng Y, Wei X, Chen D, Zhao X, Jia P . Gold embedded chitosan nanoparticles with cell membrane mimetic polymer coating for pH-sensitive controlled drug release and cellular fluorescence imaging. J Biomater Appl. 2020; 35(7):857-868. DOI: 10.1177/0885328220952594. View

20.

Yu X, Pham J, Subramani C, Creran B, Yeh Y, Du K . Direct patterning of engineered ionic gold nanoparticles via nanoimprint lithography. Adv Mater. 2012; 24(47):6330-4. DOI: 10.1002/adma.201202776. View